Actualités et communiqués de presse BioVie 2026 | BIVI | ISIN US09074F5044

Actualités Eulerpool BioVie

Actualités de l'action BioVie

BioVie est suivi par de nombreux journalistes et investisseurs dans le monde. Nous rassemblons ici les dernières actualités concernant BioVie.

12 février·
Yahoo
BioVie highlights bezisterim research at ACP meeting
12 février·
Benzinga
BioVie Announces Its Two Abstracts From Studies On Bezisterim To Treat Alzheimer's Disease, Long COVID Accepted At 2026 American College of Psychiatrists Annual Meeting
10 novembre·
Benzinga
BioVie Q1 EPS $(0.98) Misses $(0.79) Estimate
17 octobre·
Yahoo
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
8 octobre·
SeekingAlpha
BioVie Inc. - Special Call
26 septembre·
Yahoo
BioVie and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
26 septembre·
Yahoo
BioVie to Host Live Investor Webinar and Q&A on Oct. 8
9 août·
Yahoo
New to The Street to Air Show #683 on Bloomberg, Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals
8 août·
Benzinga
S&P 500 Moves Higher; Under Armour Shares Tumble After Q1 Results
8 août·
Benzinga
BioVie shares are trading lower after the company priced a $12M public offering of 6M units at $2.00 per unit.
8 août·
Benzinga
Dow Surges 300 Points; American Axle & Manufacturing Posts Upbeat Earnings
8 août·
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
8 août·
Benzinga
Reported Earlier, BioVie Prices $12M Public Offering Of 6M Units Consisting Of Common Stock And Warrants At $2.00 Per Unit
9 juillet·
Benzinga
BioVie Announces Data Highlighting Bezisterim At 7th World Aging And Rejuvenation Conference
27 juin·
Yahoo
New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HIT), and Commercialville T.V.
26 juin·
Yahoo
BioVie Highlights Patient-Centric Design of SUNRISE-PD Trial at Advanced Therapeutics in Movement & Related Disorders® Congress (ATMRD)
24 juin·
Benzinga
BioVie To Present Decentralized Design And Patient Experience Of Phase 2 SUNRISE-PD Clinical Trial Evaluating Bezisterim In Early Parkinson's Disease At Advanced Therapeutics In Movement & Related Disorders Congress
16 juin·
Yahoo
New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST
6 juin·
Yahoo
New to The Street Announces Upcoming Bloomberg Air Dates Featuring FLOKI, BioVie Pharmaceuticals, Beeline, Arrive AI, and Commercialville
14 avril·
Yahoo
New to The Street's FOX Business "Late Night T.V." Special Airs Tonight – Show #650 – Featuring Health In Tech CEO Julia Qian (NASDAQ:HIT), BioVie's Dr. Joseph Palumbo (NASDAQ:BIVI), eXoZymes Co-Founder & VP of Research Tyler Korman (EXOZ), and ARRIVE AI Founder & CEO Dan O'Toole (ARAI)

Communiqués de presse relatifs à l'action BioVie

BioVie publie régulièrement sur son site web des communiqués pertinents pour les investisseurs.

BioVie News 2026

Cette page contient toutes les actualités actuelles, analyses et communiqués de presse pour l'action BioVie (BIVI, ISIN : US09074F5044). Cela inclut les actualités Eulerpool, les analyses d'entreprise et les communiqués de presse officiels. Les données sont mises à jour régulièrement pour fournir aux investisseurs un aperçu complet des derniers développements chez BioVie.

BioVie Action

BioVie BioVie Inc, based in Carson City, Nevada, is a biopharmaceutical company focused on developing drug therapies for liver disease and neurodegenerative conditions. The company, listed on 14 January 2014, employs 18 people and operates in the Health Care sector. Its key drug candidates include BIV201 for refractory ascites in liver cirrhosis and NE3107, an oral ERK inhibitor targeting neuroinflammation and insulin resistance.